Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals - Agilon Health (NYSE:AGL)

Zinger Key Points

JP Morgan analyst revises Agilon Health's FY25 revenue estimate to $5.926B, reflecting a transitional year. Agilon's FY26 revenue estimate updated to $6.594B, with adjusted EBITDA loss expected at $23M. Next: Get access to a new market-moving chart every day featuring a stock flashing clear technical signals. See today's pick now.

J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc. AGL following fourth- quarter results posted last month .

Last month, the company reported a fourth-quarter 2024 adjusted EPS of $(0.26), missing the consensus estimate of $(0.23). However, sales for the quarter totaled $1.52 billion, which is in line with expectations .

The analyst’s revised estimates reflect an updated outlook on AGL’s recovery timeline based on management’s recent commentary.

With 2025 expected to be a year of transition, the company aims to address specific challenges while navigating another year of high trends, positioning itself to achieve its targets for 2026/2027, adds the analyst.

The analyst estimates revenue of $1.502 billion (vs. $1.503 billion consensus) and adjusted EBITDA of $16 million (in line with consensus) in the first quarter of FY25.

For FY25, Gill revised the revenue estimate to $5.926 billion (vs. $5.928 billion consensus) from $6.453 billion earlier while adjusted EBITDA loss estimate remains unchanged at $77 million (vs. consensus loss of $78 million).

For FY26, the analyst updated the revenue estimate to $6.594 billion (vs. consensus mean of $6.665 billion) from $7.319 billion prior and adjusted EBITDA loss estimate changes to $23 million (vs. consensus loss of $22 million) from loss of $10 million prior.

Investors can gain exposure to the stock via Fidelity Disruptive Medicine ETF FMED and SPDR S&P Health Care Services ETF XHS .

Price Action: AGL shares are down 0.48% at $4.18 at the last check Tuesday.

Read Next:

Cloudflare Launches Cloudforce One And Security Posture Management For Real-Time Threat Response

Image via Shutterstock.

AGL Agilon Health Inc $4.23 0.71%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Edge Rankings

Momentum 57.94 Growth 87.16 Quality - Value 65.59

Price Trend

Short Medium Long Overview FMED Fidelity Disruptive Medicine ETF $24.29 -0.53% XHS SPDR S&P Health Care Services ETF $96.64 -0.35% Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Earnings Analyst Ratings Options Dividends IPOs

date ▲ ▼	ticker ▲ ▼	name ▲ ▼	Price Target ▲ ▼	Upside/Downside ▲ ▼	Recommendation ▲ ▼	Firm ▲ ▼

Click to see more Analyst Ratings updates

Analyst Calendar

Join Benzinga Edge and unlock all the major upgrades, downgrades, and changes to the market's most accurate analysts.

Click to Join

---

Posted In: Analyst Color Equities News Reiteration Small Cap Top Stories Analyst Ratings Trading Ideas Briefs Expert Ideas Stories That Matter Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free! Already a member? Sign in